2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects

Rheumatology (United Kingdom)

Volumn 56, Issue 11, 2017, Pages 1884-1893

  Rider, Lisa G ^a   Ruperto, Nicolino ^b   Pistorio, Angela ^b   Erman, Brian ^c   Bayat, Nastaran ^a   Lachenbruc, Peter A ^a   Rockette, Howard ^d   Feldman, Brian M ^e   Huber, Adam M ^f   Hansen, Paul ^g   Oddis, Chester V ^h   Lundberg, Ingrid E ⁱ   Amato, Anthony A ^j   Chinoy, Hector ^k,l   Cooper, Robert G ^m   Chung, Lorinda ⁿ   Danko, Katalin ^o   Fiorentino, David ⁿ   De la Torre, Ignacio García ^p   Reed, Ann M ^q   Song, Yeong Wook ^r   Cimaz, Rolando ^s   Cuttica, Rubén J ^t   Pilkington, Clarissa A ^u   Martini, Alberto ^b,v   van der Net, Janjaap ^w   Maillard, Susan ^u   Miller, Frederick W ^a   Vencovsky, Jiri ^x   Aggarwal, Rohit ^h   Christopher Stine, Lisa ^y   Criscione Schreiber, Lisa ^y   Crofford, Leslie ^y   Cronin, Mary E ^y   Gordon, Patrick ^y   Hengstman, Gerald ^y   Katz, James D ^y   Mammen, Andrew ^y   Marder, Galina ^y   McHugh, Neil ^y   Schiopu, Elena ^y   Wolfe, Gil ^y   Wortmann, Robert ^y   Apaz, Maria ^y   Bowyer, Suzanne ^y   Constantin, Tamás ^y   Curran, Megan ^y   Davidson, Joyce ^y   Griffin, Thomas ^y   Jones, Olcay ^y   Kim, Susan ^y   Lang, Bianca ^y   Lindsley, Carol ^y   Lovell, Daniel ^y   Magalhaes, Claudia Saad ^y   Pachman, Lauren M ^y   Ponyi, Andrea ^y   Punaro, Marilynn ^y   Quartier, Pierre ^y   Ramanan, Athimalaipet V ^y   Ravelli, Angelo ^y   Rennebohm, Robert ^y   Van Royen Kerkhof, Annet ^y   Sherry, David D ^y   Silva, Clovis A ^y   Stringer, Elizabeth ^y   Wallace, Carol ^y   Ascherman, Dana ^y   Barohn, Richard ^y   Benveniste, Olivier ^y   De Bleecker, Jan ^y   Callen, Jeffrey ^y   Charles Schoeman, Christina ^y   Danoff, Sonye ^y   Dastmalchi, Maryam ^y   Dimachkie, Mazen ^y   Di Martino, Steve ^y   Dourmishev, Lyubomir ^y   Ernste, Floranne ^y   Gono, Takahisa ^y   Isenberg, David ^y   Katsumata, Yasuhiro ^y   Kissel, John ^y   Leff, Richard L ^y   Levine, Todd ^y   Mann, Herman ^y   Marie, Isabelle ^y   Merola, Joseph ^y   Olesinska, Marzena ^y   Olsen, Nancy ^y   Pipitone, Nicolo ^y   Ramchandren, Sindhu ^y   Rutkove, Seward ^y   Saketkoo, Lesley Ann ^y   Schiffenbauer, Adam ^y   Selva O'Callaghan, Albert ^y   Shinjo, Samuel Katsuyuki ^y   Shupak, Rachel ^y   Swierkocka, Katarzyna ^y   de Visser, Marianne ^y   Wanschitz, Julia ^y   Werth, Victoria P ^y   Whitt, Irene ^y   Ytterberg, Steven ^y   Avcin, Tadej ^y   Becker, Mara ^y   Beresford, Michael W ^y   Dressler, Frank ^y   Dvergsten, Jeffrey ^y   Ferriani, Virginia Paes Leme ^y   Flato, Berit ^y   Gerloni, Valeria ^y   Henrickson, Michael ^y   Hinze, Claas ^y   Hoeltzel, Mark ^y   Ibarra, Maria ^y   Ilowite, Norman ^y   Imundo, Lisa ^y   Kingsbury, Daniel ^y   Magnusson, Bo ^y   Maguiness, Sheilagh ^y   Mathiesen, Pernille ^y   McCann, Liza ^y   Nielsen, Susan ^y   de Oliveira, Sheila Knupp Feitosa ^y   Passo, Murray ^y   Rabinovich, Egla ^y   Rivas Chacon, Rafael ^y   Robinson, Angela Byun ^y   Rouster Stevens, Kelly ^y   Russo, Ricardo ^y   Rutkowska Sak, Lidia ^y   Sallum, Adriana ^y   Sanner, Helga ^y   Schmeling, Heinrike ^y   Selcen, Duygu ^y   Shaham, Bracha ^y   Spencer, Charles H ^y   Sundel, Robert ^y   Tardieu, Marc ^y   Thatayatikom, Akaluck ^y   Wahezi, Dawn ^y   Zulian, Francesco ^y   more..

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b G GASLINI INSTITUTE   (Italy)

^c SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f IWK HEALTH CENTRE   (Canada)

^g UNIVERSITY OF OTAGO   (New Zealand)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁿ STANFORD UNIVERSITY   (United States)

^o UNIVERSITY OF DEBRECEN   (Hungary)

^p HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^q DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r Seoul National University   (South Korea)

^s UNIVERSITY OF FLORENCE   (Italy)

^t UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^u GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^v UNIVERSITY OF GENOA   (Italy)

^w UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^x CHARLES UNIVERSITY   (Czech Republic)

^y NONE

more..

Author keywords

1000Minds software; Conjoint analysis; Dermatomyositis; Hybrid measure; Juvenile dermatomyositis; Outcome assessment; Polymyositis; Response criteria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; MUSCLE ENZYME;

ADULT; ADULT DISEASE; ARTICLE; CHILD HEALTH CARE; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CONSENSUS; DERMATOMYOSITIS; DISEASE CLASSIFICATION; EXTRAMUSCULAR GLOBAL ACTIVITY SCORE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERRATER RELIABILITY; JUVENILE DERMATOMYOSITIS; MANUAL MUSCLE TEST; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PHYSICAL SUMMARY SCORE OF THE CHILD HEALTH QUESTIONNAIRE PARENT FORM 50; PHYSICIAN GLOBAL ACTIVITY SCORE; POLYMYOSITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; CONSENSUS DEVELOPMENT; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; STATISTICAL MODEL; TREATMENT OUTCOME;

AREA UNDER CURVE; DERMATOMYOSITIS; HUMANS; LOGISTIC MODELS; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; POLYMYOSITIS; TREATMENT OUTCOME;

EID: 85032837614     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kex226     Document Type: Article

References (38)

1. Rider LG, Werth VP, Huber AM et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 2011;63 (Suppl 11):S118-57
2. Ruperto N, Martini A. Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO). Arch Dis Child 2011;96:596-601
3. Miller FW, Rider LG, Chung YL et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001;40:1262-73
4. Ruperto N, Ravelli A, Pistorio A et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008;59:4-13
5. Ruperto N, Ravelli A, Murray KJ et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003;42:1452-9
6. Rider LG, Giannini EH, Harris-Love M et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003;30:603-17
7. Rider LG, Giannini EH, Brunner HI et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50:2281-90
8. Ruperto N, Pistorio A, Ravelli A et al. The Pediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res 2010;62:1533-41
9. Lazarevic D, Pistorio A, Palmisani E et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013;72:686-93
10. Hasija R, Pistorio A, Ravelli A et al. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum 2011;63:3142-52
11. Hansen P, Ombler F. A new method for scoring additive multi-attribute value models using pairwise rankings of alternatives. J Multi-Crit Decis Anal 2008;15:87-107
12. Neogi T, Jansen TL, Dalbeth N et al. 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 2015;67:2557-68
13. Utz KS, Hoog J, Wentrup A et al. Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis. Ther Adv Neurol Disord 2014;7:263-75
14. Amaya-Amaya M, Gerard K, Ryan M. Discrete choice experiments in a nutshell. In: Ryan M, Gerard K, Amaya-Amaya M, eds. Using discrete choice experiments to value health and health care. Dordrecht: Springer, 2008
15. de Bekker-Grob E, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ 2012;21:145-72
16. Singh JA, Solomon DH, Dougados M et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-52
17. Ruperto N, Meiorin S, Iusan SM et al. Consensus procedures and their role in pediatric rheumatology. Curr Rheumatol Rep 2008;10:142-6
18. Delbecq A, Van de Ven A, Gustafson D. Group techniques for program planning. a guide to nominal group and Delphi processes. Glenview, IL: Scott, Foresman and Company, 1975
19. Ruperto N, Pistorio A, Oliveira S et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet 2016;387:671-8
20. Rider LG, Lee J, Jansen A et al. Defining clinically relevant changes in core set activity measures for adult and juvenile idiopathic inflammatory myopathies (IIM). Arthritis Rheum 2011;63 (Suppl):S89
21. Lundberg IE, Svensson J. Registries in idiopathic inflammatory myopathies. Curr Opin Rheumatol 2013;25:729-34
22. Zong M, Dorph C, Dastmalchi M et al. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Ann Rheum Dis 2014;73:913-20
23. Oddis CV, Reed AM, Aggarwal R et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 2013;65:314-24
24. Chung L, Genovese MC, Fiorentino DF. A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 2007;143:763-7
25. Dastmalchi M, Grundtman C, Alexanderson H et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis 2008;67:1670-7
26. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975;292:344-7
27. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). New Engl J Med 1975;292:403-7
28. Youden W. Index for rating diagnostic tests. Cancer 1950;3:32-5
29. American College of Rheumatology Committee to Reevaluate Improvement Criteria. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. Arthritis Rheum 2007;57:193-202
30. Rider LG, Aggarwal R, Pistorio A et al. International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 2017;76:782-91
31. Aggarwal R, Rider LG, Ruperto N et al. International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 2017;76:792-801
32. Neogi T, Aletaha D, Silman AJ et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum 2010;62:2582-91
33. Johnson SR, Naden RP, Fransen J et al. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol 2014;67:706-14
34. Van Den Hoogen F, Khanna D, Fransen J et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47
35. Streiner DL. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry 2002;47:262-6
36. Villalba L, Hicks JE, Adams EM et al. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 1998;41:392-9
37. Cherin P, Herson S, Wechsler B et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 1991;91:162-8
38. Lundberg IE, Miller FW, Tjä rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 2016;280:39-51